Deepak Nitrite subsidiary settles factory violation for ₹3 lakh

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Deepak Chem Tech Limited settled a factory rule violation for ₹3,00,000
  • The order was passed by the Gujarat Settlement Officer on August 25, 2026
  • Violation pertains to Rule 102 of the Gujarat Factories Rules, 1963
  • Deepak Nitrite stated no material financial impact from the settlement
powered bylight_fuzz_icon
49210239

*this image is generated using AI for illustrative purposes only.

Deepak Nitrite disclosed that its wholly owned subsidiary, Deepak Chem Tech Limited, settled a regulatory violation with the Gujarat government on August 25, 2026. The settlement resolves a contravention of factory rules without material financial impact on the listed entity.

The Settlement Officer, Chief Inspector cum facilitator for factories in Ahmedabad, passed the order under Section 114 of the Occupational Safety, Health and Working Condition Code, 2020. The payment addresses a specific breach of Rule 102 of the Gujarat Factories Rules, 1963.

Settlement Details

Detail Information
Authority Settlement Officer, Chief Inspector cum facilitator for factories, Ahmedabad
Violation Rule 102 of Gujarat Factories Rules, 1963
Settlement Amount ₹3,00,000
Date of Order August 25, 2026
Regulatory Basis Section 114, Occupational Safety, Health and Working Condition Code, 2020

Deepak Nitrite filed this disclosure pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The filing references Para-A-20 of Part A of Schedule III and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Financial Impact Assessment

The company explicitly stated that the settlement will have no material financial impact beyond the ₹3,00,000 payment mentioned above. There are no additional penalties or operational restrictions noted in the disclosure.

This regulatory action affects only the subsidiary level and does not indicate broader compliance issues across the group’s manufacturing facilities.

Historical Stock Returns for Deepak Nitrite

1 Day5 Days1 Month6 Months1 Year5 Years
+1.20%-1.66%+6.15%+10.24%-4.33%-16.31%

Will Deepak Nitrite implement enhanced internal compliance audits across other subsidiaries to prevent similar regulatory breaches?

How might this settlement influence the Gujarat government's future enforcement stance on factory safety regulations for chemical manufacturers?

Are there any pending or potential environmental clearances for Deepak Chem Tech that could be impacted by this prior violation record?

Deepak Nitrite accepts Puneet Sharma resignation as Life Sciences head

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Puneet Sharma resigns as SBU Head - Life Sciences at Deepak Nitrite
  • Resignation effective August 21, 2026, following a three-month notice period
  • Sharma cited a new career opportunity outside the organization
  • Transition includes handover of global business development engagements
powered bylight_fuzz_icon
48870247

*this image is generated using AI for illustrative purposes only.

Deepak Nitrite has accepted the resignation of Puneet Sharma from his position as SBU Head - Life Sciences, effective close of business on August 21, 2026.

The company disclosed the change under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sharma served in the role overseeing the Life Sciences division, which includes agrochemical and pharma intermediates, personal care, and emerging platforms.

Resignation Details

Sharma tendered his resignation on May 23, 2026, citing a decision to pursue an opportunity outside the organization for the next chapter of his career. He completed a three-month contractual notice period before his relieving date.

In his resignation letter addressed to Maulik Mehta, Sharma highlighted his tenure at Deepak Nitrite as a defining phase of his professional life. He noted the trust and autonomy extended by management during his time shaping the division.

Transition Plan

Sharma committed to ensuring a seamless transition process. This includes covering ongoing business development engagements with global innovators and maintaining progress on technology platforms. He stated he would work closely with management to onboard his successor.

The disclosure was signed by Arvind Bajpai, Company Secretary, on August 21, 2026.

Historical Stock Returns for Deepak Nitrite

1 Day5 Days1 Month6 Months1 Year5 Years
+1.20%-1.66%+6.15%+10.24%-4.33%-16.31%

How will Deepak Nitrite's Life Sciences division maintain its competitive edge in agrochemical and pharma intermediates during the leadership transition?

Will the company appoint an internal successor for Puneet Sharma's role or seek external talent with specific expertise in emerging technology platforms?

Could this executive departure signal broader strategic shifts or restructuring within Deepak Nitrite's high-growth Life Sciences segment?

More News on Deepak Nitrite

1 Year Returns:-4.33%